Emerging Drug List is an online series that profiles new drugs and vaccines while they are at an early stage of development, prior to Health Canada approval. Designed as a “heads up” for those who anticipate, plan, and manage drug coverage and prescribing decisions, these summaries identify drugs that are expected to have a high impact on utilization, patient outcomes, hospital operations, or drug budgets. Summaries include a description of the drug, patient indications, regulatory status, alternative drug treatments, adverse effects, cost, a summary of the early evidence, and general comments. Peer-reviewed by the Canadian Agency for Drugs and Technologies in Health’s internal staff.
Emerging Drug List are available to be downloaded in an electronic format only.